Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PLCG1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of PLCG1 mRNA | decreases expression | 18648102
|
D000079 |
Acetaldehyde |
PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein]] | affects localization|affects reaction|decreases reaction | 17991733
|
D000079 |
Acetaldehyde |
PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]] | affects localization|affects reaction|decreases reaction | 17991733
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of PLCG1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PLCG1 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of PLCG1 protein | decreases expression | 16483693
|
C030233 |
benzo(a)pyrene-1,6-quinone |
benzo(a)pyrene-1,6-quinone results in increased phosphorylation of PLCG1 protein | increases phosphorylation | 19166869
|
C018003 |
benzo(a)pyrene-3,6-quinone |
benzo(a)pyrene-3,6-quinone results in increased phosphorylation of PLCG1 protein | increases phosphorylation | 19166869
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PLCG1 mRNA | affects cotreatment|decreases expression | 20360939
|
C043561 |
chrysin |
BCL2 protein inhibits the reaction [chrysin results in increased degradation of PLCG1 protein] | decreases reaction|increases degradation | 16215670
|
C043561 |
chrysin |
chrysin results in increased degradation of PLCG1 protein | increases degradation | 16215670
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PLCG1 mRNA | affects cotreatment|decreases expression | 20360939
|
D000431 |
Ethanol |
[Ethanol co-treated with sodium arsenite] results in increased localization of PLCG1 protein | affects cotreatment|increases localization | 18182400
|
D005472 |
Fluorouracil |
PLCG1 protein results in decreased susceptibility to Fluorouracil | decreases response to substance | 17531112
|
D006534 |
Heptachlor Epoxide |
Heptachlor Epoxide results in increased expression of PLCG1 protein | increases expression | 11246134
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of PLCG1 mRNA | affects cotreatment|increases expression | 17183730
|
C506002 |
ircinin-1 |
ircinin-1 results in increased cleavage of PLCG1 protein | increases cleavage | 16163705
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of PLCG1 mRNA | increases expression | 12057914
|
C064769 |
N-acetylsphingosine |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased degradation of PLCG1 protein] | decreases reaction|increases degradation | 16215670
|
C064769 |
N-acetylsphingosine |
N-acetylsphingosine results in increased degradation of PLCG1 protein | increases degradation | 16215670
|
D009638 |
Norepinephrine |
Norepinephrine results in increased expression of and results in increased activity of PLCG1 protein | increases activity|increases expression | 19225867
|
D009638 |
Norepinephrine |
Norepinephrine results in increased expression of PLCG1 mRNA | increases expression | 19225867
|
D009638 |
Norepinephrine |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of and results in increased activity of PLCG1 protein] | decreases reaction|increases activity|increases expression | 19225867
|
D009638 |
Norepinephrine |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCG1 mRNA] | decreases reaction|increases expression | 19225867
|
D010100 |
Oxygen |
Oxygen deficiency results in increased expression of PLCG1 mRNA | increases expression | 17914565
|
D010126 |
Ozone |
Ozone results in decreased expression of PLCG1 mRNA | decreases expression | 16330353
|
D010269 |
Paraquat |
Paraquat results in decreased expression of PLCG1 mRNA | decreases expression | 17077588
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of and results in increased activity of PLCG1 protein] | decreases reaction|increases activity|increases expression | 19225867
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCG1 mRNA] | decreases reaction|increases expression | 19225867
|
C059514 |
resveratrol |
resveratrol results in decreased expression of PLCG1 mRNA | decreases expression | 12569576
|
C017947 |
sodium arsenite |
[Ethanol co-treated with sodium arsenite] results in increased localization of PLCG1 protein | affects cotreatment|increases localization | 18182400
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PLCG1 mRNA | decreases expression | 12760830
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PLCG1 mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PLCG1 mRNA | increases expression | 18796159
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of PLCG1 mRNA | increases expression | 16917069
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of PLCG1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
12.93 | 17676605 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
12.93 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
12.93 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.72 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.71 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
9.71 | 11192467 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.65 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.86 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
8.86 | 16759491 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.37 | 17638652 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
10.46 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
10.46 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
10.46 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.29 | 17620307 16434500 19052882 18056438 19061943 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.29 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.47 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.67 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.54 | 11874814 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.09 | 15451040 15451039 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.20 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.20 | 16162502 16183991 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.00 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.02 | 17963324 16511603 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.02 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.61 | 10982225 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.59 | 15513904 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.83 | 20872349 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
8.39 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.39 | 17497229 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.36 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.51 | 15570426 |
MESH:D001249 |
Asthma |
|
Acetaldehyde |
5.20 | 9600491 |
MESH:D001249 |
Asthma |
|
Ozone |
5.20 | 17854713 16373670 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
6.65 | 16391483 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.65 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.25 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
2.25 | 8570775 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.25 | 18316065 18775368 18985861 18177632 17157402 19460635 17507914 15238991 17688650 19232924 20603192 18940202 18558336 16609825 18396377 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.79 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.96 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.84 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.54 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.54 | 8888407 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.06 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.87 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.87 | 15136595 16557594 18357371 16595493 16110121 19217205 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Heptachlor Epoxide |
2.87 | 8738476 15770527 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
2.87 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.87 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.87 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.50 | 15516495 17626835 18417511 19059883 18315731 16777450 14754758 |
MESH:D002056 |
Burns |
|
Ethanol |
4.43 | 16374292 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.51 | 16183385 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.44 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.59 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.59 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
16.26 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
16.26 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
16.26 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
16.26 | 20101231 20214788 17428255 20514400 16698587 17978847 20007298 17138121 3581430 10737359 16540662 18971187 19335982 19171122 19383236 18665156 20524982 16935385 19107877 20727157 18393292 18506893 19519916 19919837 18056438 19539802 20432363 19208518 18210153 17055752 16807293 3084413 18494052 16878318 16830150 16288022 17761372 19701751 18691550 17173139 16681979 16569478 18785209 16502159 21159647 19418558 19052882 16328049 18978308 18788625 11831363 10672840 16779866 20512989 17162532 20084675 20935162 19822196 19394651 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
16.26 | 18788625 15763234 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
16.26 | 17045692 16799960 17088986 16332177 17971768 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
16.26 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
16.26 | 17306315 16507464 15276417 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.36 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.14 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.14 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.23 | 18986760 16280240 17066447 16757204 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.23 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.23 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
10.88 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
10.88 | 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
10.88 | 16120746 18670907 18850075 |
MESH:D002310 |
Cardiomyopathy, Alcoholic |
|
Acetaldehyde |
6.25 | 10525098 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.32 | 15458977 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
5.31 | 8216760 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.45 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.75 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
14.75 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
14.75 | 7505956 17174075 21159647 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.75 | 19524636 20056578 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.63 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.69 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.69 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
2.98 | 9022650 19486331 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.47 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.63 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.63 | 15668235 15340226 8697196 12621046 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.91 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.77 | 17725105 17169374 16510598 17287894 18772588 16340194 15001691 17016597 17018589 17172411 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.77 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.62 | 17454858 15148649 18288408 18802399 17016601 16391804 17094418 16282729 18383874 20501625 15289873 16524972 18949393 16331619 16303861 17401013 17594712 17695437 18448328 14970324 17255274 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.62 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.61 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
3.68 | 10194807 15513904 11198716 15451040 15451039 11873399 19302082 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.68 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.68 | 16575769 17688650 8888407 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.79 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.56 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.59 | 11298694 18759878 2524372 11906362 8970840 8156756 14531868 12868966 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.28 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.59 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.03 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.03 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.77 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
24.58 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
24.58 | 18692083 9653073 6679447 11289319 7440962 16192314 9328219 18289764 6482804 1440618 8291058 9022650 18648102 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
24.58 | 19164858 16485898 2444490 16177239 19739265 16109766 19416960 19370779 14725611 12958197 12540782 17522070 11743745 11421492 10663392 17562736 18713872 12705907 11529661 17906064 19420014 15968718 12594235 10774834 11739529 19085960 15619225 11287661 11461765 16081117 14550746 16393943 12153990 12392966 19923254 14986274 10915739 18071297 16781746 11834606 16227642 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
24.58 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
24.58 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Prazosin |
24.58 | 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
24.58 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
24.58 | 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
24.58 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.87 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.59 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.60 | 20016425 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.84 | 1851702 |
MESH:D004487 |
Edema |
|
resveratrol |
6.19 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.19 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.67 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.81 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.17 | 15821434 15328337 17637181 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.62 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.93 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.69 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
6.80 | 821787 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
6.80 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.40 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.07 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.84 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.89 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.98 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
6.98 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
6.98 | 16785472 15173087 17638652 16337965 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
17.18 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
17.18 | 16409862 19236843 18620774 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
17.18 | 16917069 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
17.18 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.43 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.07 | 16946407 15513904 10194807 15451040 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.66 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.91 | 18558336 8888407 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.82 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.79 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.73 | 20067830 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
4.99 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
10.36 | 16983495 |
MESH:D005756 |
Gastritis |
|
Ethanol |
10.36 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.45 | 16452187 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.78 | 16145905 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.93 | 11124998 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.82 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.23 | 15162350 15102660 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.21 | 11294989 10048152 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.19 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.30 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.67 | 16120746 12621046 15340226 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.95 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.97 | 12676792 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.64 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 15340226 18606429 8697196 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
12.26 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
12.26 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Prazosin |
12.26 | 12727271 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.80 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.82 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.71 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.82 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.40 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.10 | 17488730 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
4.78 | 6740701 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.42 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
6.42 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.42 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.01 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
11.01 | 17255318 9205823 17963957 12878042 17237260 |
MESH:D007249 |
Inflammation |
|
resveratrol |
11.01 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.01 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.31 | 16624496 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.39 | 10783313 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.42 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.79 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.44 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.44 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.41 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
9.41 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.41 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.37 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.37 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.37 | 16985049 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.99 | 15451040 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.11 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
7.59 | 16766008 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.59 | 16087638 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.47 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.65 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.40 | 18522880 18407596 18665156 20032147 19638242 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
6.40 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.87 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.06 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
3.43 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.43 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.43 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.70 | 19784758 12587719 12969438 19014921 19460945 16610002 16611625 11587558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.70 | 17034775 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.43 | 17207112 17347304 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.04 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
20.57 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
20.57 | 18754104 2862719 21047994 18648771 20118626 19090486 19427195 21071580 19833225 21278145 18978307 19642983 16942905 19254457 20405173 19551842 9163691 20101389 19812893 2422723 10737359 18644402 20452335 19690152 19996281 19426721 15885732 12112319 19256749 19499222 20434301 12771043 19850985 19294768 19255062 18977376 20492335 20137499 19073162 19638242 20583210 15175105 20501860 21167192 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
20.57 | 17045692 18383874 15113037 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
Heptachlor Epoxide |
20.57 | 11246134 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
20.57 | 19073162 20405173 19812893 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
20.57 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.57 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
12.93 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
12.93 | 6587162 3712494 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
12.93 | 18308698 16267830 17174075 2563599 18164116 19519916 21159647 19009564 19126423 19539802 18544905 9362446 18253720 18775883 17942915 18282651 19004024 17854601 18079962 16842330 18093689 3124819 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.93 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.01 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.01 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.03 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
14.01 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
14.01 | 18339021 |
MESH:D055370 |
Lung Injury |
|
Ozone |
14.01 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Acetaldehyde |
8.18 | 17372256 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.18 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
8.18 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
8.18 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.18 | 19931552 17077188 16712894 15276417 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.18 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.56 | 15086387 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.09 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.69 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.02 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
2.97 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.36 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.36 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.34 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.97 | 18411066 15451040 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.17 | 17112576 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.87 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.03 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.46 | 18986760 16757204 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.31 | 17935668 16267019 14749477 17164350 17049120 16490592 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.64 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.82 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.03 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.94 | 16317513 17125593 16525036 16456233 17188708 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.41 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.41 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
4.67 | 15642760 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.53 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.63 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.40 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.40 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
4.81 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.81 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.48 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.48 | 20056578 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.55 | 9884423 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.54 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.00 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
11.29 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.29 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.29 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
12.98 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
12.98 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
12.98 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.19 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.89 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.29 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.22 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.22 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.79 | 3988306 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.04 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.37 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.21 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.22 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
8.22 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
8.22 | 16929163 16500647 15113037 19003803 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.26 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.73 | 12911755 11181820 16140633 16510128 15824117 11445065 15451049 11124998 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.21 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
5.20 | 11026799 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.91 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.24 | 6228378 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
17.25 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
17.25 | 18007984 18381685 18929643 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
17.25 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.36 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
14.95 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.95 | 11896295 11399792 11118676 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
14.95 | 20603192 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
5.18 | 10903871 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.72 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.72 | 15767336 17675339 17804756 17636462 16731767 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.72 | 16039940 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.31 | 11422049 12752131 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.83 | 17997886 16324872 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.82 | 15538739 18286688 18722050 16160472 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.35 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.16 | 16314181 17058453 17520802 15827377 16317513 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
8.74 | 18339021 17627322 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
8.74 | 11700416 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.58 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.83 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
8.35 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
8.35 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.96 | 19155313 |
MESH:D012220 |
Rhinitis |
|
Acetaldehyde |
4.55 | 17050345 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.04 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.01 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
9.01 | 9754883 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.01 | 15475178 14763951 1511512 16876388 11738929 17978042 11044598 3137016 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
8.86 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.86 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.86 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.97 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.97 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.31 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.33 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
3.33 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.33 | 16424979 18567086 18396642 17498489 15786421 19015929 17172411 17522103 19084572 16951190 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.33 | 11906479 17189318 17918041 9211565 16755016 9562338 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.28 | 16321402 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.06 | 9754883 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.31 | 12563064 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
5.22 | 3261545 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.97 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.55 | 1399818 6587162 6582329 7505956 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.55 | 7505956 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.33 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.33 | 16227395 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.00 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.29 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
7.78 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.78 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.78 | 16452187 11723127 17306315 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.42 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.09 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.77 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
14.77 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
14.77 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.77 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.92 | 17044934 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.20 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.08 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |